Fragmented assays can create friction between R&D, development and QC. As cell and gene therapies move towards commercialisation, could a single platform bring multiple analytical assessments together within a single workflow? Learn more: https://bit.ly/3T4xnpB

Direct RNA offers a unique view of native RNA, but scaling experiments hasn’t been easy. Our new Direct RNA Barcoding Kit enables multiplexing, so you can run more samples and uncover RNA biology that single-sample studies miss. https://bit.ly/4aNcWn6

Dr. Ahmad Abou Tayoun is leading efforts to streamline genomics research in the Middle East. Using Oxford Nanopore sequencing, his team studies multiple layers of complexity in one comprehensive approach, helping researchers reduce time and focus on discovery.

At #nanoporeconf, Luke Snell challenged a common assumption about metagenomics: detecting more doesn’t necessarily mean using more antibiotics. In his observations, clearer pathogen identification often enabled a more focused approach to antimicrobial use. https://bit.ly/4xz0lgZ

Generate comprehensive transcriptome profiles from bulk or single-cell populations to monitor off-target effects, confirm the integrity of therapeutic constructs, and verify fusion events or splicing patterns critical to product safety and efficacy. https://bit.ly/4vM7lGL

All the critical quality attributes. One run. One simplified protocol. Amanda Hughes' research explores how nanopore sequencing could transform mRNA therapeutics QC in GMP environments. Learn more: https://bit.ly/4eVeZbp

At #nanoporeconf, Kimberley Billingsley shared how she and her team were amazed by the new cDNA kits, which almost double the transcript length of the previous kit. Watch the full talk here: https://bit.ly/4oRq00u

Oxford Nanopore technology has the potential to cut molecular testing from weeks to hours - while delivering more comprehensive insights. Hear Claire Attwooll and Rita Shannovich discuss the future potential of Adaptive Sampling for routine testing. https://bit.ly/4hcSPmh

David Thomas framed it clearly: insight without the ability to act has limits. Faster sequencing workflows (RUO) mean researchers can generate genomic data sooner and explore potential drivers of disease earlier. https://bit.ly/4esA4s9

Two DNA modifications. One method that can't tell them apart. Decades of research that may need a second look. New preprint out now using Oxford Nanopore sequencing to show what's been missing. Read here: https://www.biorxiv.org/content/10.64898/2026.07.08.736699v1

From outbreak response to routine pathogen identification, Martin McHugh shares how they’re moving beyond standard targeted sequencing, using metagenomic approaches to identify unexpected pathogens and resistance markers from a single sample. https://bit.ly/4os7Z8N

This is ORG one Learn more: https://ORG.one?utm_campaign=AnythingAnyoneAnywhere&utm_content=1783787700&utm_medium=social&utm_source=bluesky

Oxford Nanopore Technologies has been named winner of the 2026 MacRobert Award, the UK's longest-running and most prestigious prize for engineering innovation, in recognition of its pioneering nanopore sequencing technology and its global impact. https://bit.ly/3RtKm3E

The world of sequencing just got smaller… PromethION 2 Integrated brings high-output, human-scale sequencing within reach of more labs. Run up to two independent PromethION Flow Cells with integrated onboard compute for real-time sequencing and analysis. https://bit.ly/4vGeurr

Victorian Clinical Genetics Services (VCGS) has achieved ISO 15189 accreditation for a whole genome sequencing workflow using Oxford Nanopore technology, bringing this approach into fully regulated clinical practice. Learn more: https://bit.ly/44jV53x

Join us on 16 July to see how multiomic nanopore sequencing combines DNA, RNA and epigenetic analysis on one platform — with new insights into Alzheimer's biomarker discovery and a new cDNA-PCR protocol for longer reads and accurate isoforms detection. https://bit.ly/3QyWVdH

Building chromosome-level genomes no longer needs to be complex or costly. With optimised error correction on Oxford Nanopore long reads, researchers can now achieve near telomere-to-telomere assemblies faster and with fewer resources. Learn more: https://bit.ly/4vzj76A

Small box. Big capability. PromethION 2 Integrated is as powerful as it is streamlined. Designed to give more labs access to high-output sequencing, with high-performance onboard compute for real-time sequencing and analysis. See the performance data: https://bit.ly/44ttdKl

Short reads fragment the genomic picture. In the London Calling studio, Sebastian Lunke shares how they’re finally seeing the whole picture with long Oxford Nanopore reads.

Many RNAs originally annotated as non-coding may encode proteins, with signals found across UTRs and overlapping known ORFs. Mike Clark shares how Oxford Nanopore enables this kind of transcript-level insight. Learn more: https://bit.ly/3SgUa19

Every cancer insight you can imagine, & then some. A cancer-free future starts with a transformative view of the methylome, genome, & transcriptome – all from a single platform. With our unique multiomics toolkit, never see cancer the same way again. https://bit.ly/49My50k

Small box. Big impact. Hear from your peers. Learn how researchers such as Ashley Pritchard are utilising the PromethION 2 Integrated to unlock greater insights into human health and disease. When you need a multiomic view, this is the compact sequencer you can count on. https://bit.ly/3SJPBMM

Critically ill infants need rapid treatment. Ni-Chung Le, through the Asia-Pacific N‑Care Project, showed how nanopore has the potential to deliver answers in ~5 days. Watch her full talk here: https://bit.ly/4oDEDED RUO

Leveraging nanopore sequencing, the Singapore NPM program is unlocking new insights into genetic diversity to enable more precise healthcare & better outcomes for Singapore’s population. Learn more: https://bit.ly/4fynXfq

Identify microbes faster, more accurately, and at scale. Watch the webinar to learn how the rapid, end-to-end microbial barcoding workflow enables characterisation of full-length 16S and ITS regions for quicker species ID and resistance identification. https://bit.ly/4tvGgGb

Receive on the spot pathogen identification. From initial characterisation of genomes to the rapid identification of variants, portable & accessible nanopore technology enables quick responses to public health emergencies globally. https://bit.ly/4tNTfTj #WYMM

In this webinar, Marilyn Li shares data from her team’s work at Children’s Hospital of Philadelphia applying real-time Oxford Nanopore sequencing to classify acute leukaemia and tumours in minutes. Learn more: https://bit.ly/4tmD0gb For research use only.

Small box. Big Capability. New performance data. PromethION 2 Integrated is as powerful as it is streamlined. Explore genomic, epigenomic, and transcriptomic variation like never before, with fully integrated, high-output sequencing. Learn more: https://bit.ly/4ov4zlP

Hereditary cancer testing shouldn’t leave gaps. With the Oxford Nanopore hereditary cancer panel, examine 258 cancer genes in one assay and detect SNVs, CNVs, pseudogenes & methylation — transforming how we understand hereditary cancer risk. https://bit.ly/4mLQOOD

Thomas Alexander showed how adaptive sampling could deliver comprehensive leukaemia classification within days. He shared how this could improve the standard of care across both high- and low-income settings. https://bit.ly/4eM1vyq